SW
BIB icon

SkyOak Wealth’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History

SkyOak Wealth’s Portfolio BIB Stock Details BIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-9,500
Closed -$690K – 207
2020
Q2 		$690K Sell
9,500
-800
-8% -$51.1K 0.25% 95
2020
Q1 		$477K Sell
10,300
-1,240
-11% -$69.1K 0.24% 94
2019
Q4 		$713K Buy
+11,540
New +$616K 0.22% 102

Other funds holding BIB

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
CIC
Chase Investment Counsel Charlottesville, Virginia $381M AUM 69.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
CIA
Capital Investment Advisors Atlanta, Georgia $6.84B AUM 17.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank Julius Baer & Co
Bank Julius Baer & Co Zurich, Switzerland $33.2B AUM 25.01% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

SkyOak Wealth's BIB Position: Q3 2020 in Review

SkyOak Wealth sold out of ProShares Ultra NASDAQ Biotechnology (BIB) in Q3 2020, closing a stake of 9,500 shares — an estimated $690K sold.

SkyOak Wealth first reported a position in BIB in Q4 2019 and held it in 3 quarters. The position peaked at $713K in Q4 2019. 30 funds tracked by Wall St. Rank hold BIB as of Q3 2020.

  • SkyOak Wealth reported no remaining ProShares Ultra NASDAQ Biotechnology position as of Q3 2020 after selling out during the quarter.
  • SkyOak Wealth sold 9,500 ProShares Ultra NASDAQ Biotechnology shares in Q3 2020, an estimated $690K.
  • SkyOak Wealth first reported a position in ProShares Ultra NASDAQ Biotechnology in Q4 2019 and held it in 3 quarters.
  • SkyOak Wealth's ProShares Ultra NASDAQ Biotechnology position peaked at $713K in Q4 2019.
  • 30 funds tracked by Wall St. Rank held ProShares Ultra NASDAQ Biotechnology as of Q3 2020.

Based on SkyOak Wealth's 13F filing for Q3 2020, filed 3 Nov 2020.